Is Molina Healthcare Stock Underperforming the S&P 500?

Molina Healthcare, Inc. is a renowned provider of managed healthcare services under the Medicaid and Medicare programs, as well as through state insurance marketplaces. With a market cap of $16 billion, the company operates in four main segments: Medicaid, Medicare, Marketplace, and Other. Headquartered in Long Beach, California, Molina Healthcare focuses on serving underserved communities and offers health plans across multiple states in the U.S. The company’s mission is to provide cost-effective and quality healthcare access to patients.

Despite its strong presence in the healthcare sector, Molina Healthcare stock has experienced a decline of 19.1% from its 52-week high of $365.23. Over the past three months, shares of MOH have decreased by 6.9%, slightly underperforming the S&P 500 Index’s 6.5% increase. In the long term, Molina Healthcare shares have dipped by 3.5% over the past 52 weeks, trailing behind the SPX’s 9% return over the same period. On a year-to-date basis, MOH stock has gained 1.5%, while the SPX has risen by 1.7%.

The stock has been trading below its 50-day and 200-day moving averages since late May, indicating a bearish trend in the market. Following the release of its Q1 2025 results on April 23, Molina Healthcare stock fell by 5.5%. The company reported revenue of $11.2 billion, a 12.2% increase from the year-ago quarter, exceeding Street forecasts. Additionally, its adjusted EPS came in at $6.08, up 6.1% year-over-year, surpassing analysts’ estimates. However, the decline in stock was driven by rising medical costs, with the medical care ratio increasing to 89.2% due to higher-than-expected utilization in long-term care and behavioral health.

In comparison, Centene Corporation (CNC) has lagged behind MOH stock, with shares declining nearly 9% on a year-to-date basis and 16.9% over the past 52 weeks. Despite Molina Healthcare’s underperformance relative to the SPX, analysts remain moderately optimistic about its future prospects. The stock has a consensus rating of “Moderate Buy” from the 16 analysts covering it and is currently trading below the mean price target of $358.64.

In conclusion, Molina Healthcare continues to be a key player in the healthcare industry, focusing on providing quality healthcare services to underserved communities. Despite recent challenges in the market, the company’s commitment to cost-effective care and strong financial performance positions it well for future growth.